Purpose in Life Survey (PIL)

February 2, 2024 updated by: Mary Radomski

Evaluating the Prevalence of Purpose-related Existential Distress Among 2 Clinical Populations Compared to a Normative Sample

At present, there is no empirical data that specifies the likely prevalence of purpose in life disruption among various clinical populations. Between one-third and one-half of cancer survivors report some degree of existential distress during or after their treatment, but these findings are not specific to the domain of purpose in life.

To address the aforementioned gap, we propose to conduct a survey study to determine the prevalence of purpose disruption in two clinical populations and determine if the prevalence of purpose disruption in these populations is different from that of a normative population.

Study Overview

Status

Enrolling by invitation

Intervention / Treatment

Study Type

Observational

Enrollment (Estimated)

300

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Minnesota
      • Minneapolis, Minnesota, United States, 55407
        • Abbott Northwestern Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Adults who are either (1) healthy controls, (2) individuals with a qualifying cancer diagnosis, or (3) individuals with a qualifying Traumatic Brain Injury

Description

Inclusion Criteria:

  • Age 18+
  • Stage 1, 2, 3 cancer
  • Cancer types: breast cancer, non-Hodgkin's lymphoma; colorectal cancer
  • Receiving oncology services or treatment through AHCI
  • Have completed primary cancer treatment within the past 12 months
  • Able to communicate in English;
  • Able to see and read (with or without assistive devices);
  • Has access to a device (computer, phone, tablet) and an email address;
  • Access to an internet connection.
  • Has a known email address (in EPIC) and/or home telephone number
  • Adults who sustained a traumatic brain injury within the past 12 months.
  • Attending the 2022 MN State Fair

Exclusion Criteria:

  • Have declined consent for use of medical records in research during admission to AH facility

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Adults with Early Stage Cancer
Completion of a Purpose in Life Survey
Adults with Traumatic Brain Injury
Completion of a Purpose in Life Survey
Health Control Adults
Completion of a Purpose in Life Survey

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Purpose Status Question
Time Frame: Through Study Completion, about 15 minutes
A single forced-choice self-report screener question that we developed in order to characterize existential distress related to purpose in life (PSQ: "Related to living with purpose in life, right now I am: moving backwards; stalled; figuring it out; moving forward on a path").
Through Study Completion, about 15 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Work and Adjustment Scale
Time Frame: Through Study Completion, about 15 minutes
A 5-item self-report questionnaire to characterize functioning related to work, social life, leisure, home management, and relationships.
Through Study Completion, about 15 minutes
Meaning in Life Questionnaire
Time Frame: Through Study Completion, about 15 minutes
A 10-item questionnaire designed to measure 2 dimensions of meaning in life: Presence of Meaning (how much respondents feel their lives have meaning) and Search for Meaning (how much respondents strive to find meaning and understanding in their lives).
Through Study Completion, about 15 minutes
Life Engagement Test
Time Frame: Through Study Completion, about 15 minutes
A 6-item self-report questionnaire that captures the extent to which a person engages in activities that are personally valued.
Through Study Completion, about 15 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Mary V Radomski, PhD, Allina Health - Courage Kenny Rehabilitation Institute

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 1, 2022

Primary Completion (Actual)

August 31, 2023

Study Completion (Estimated)

August 31, 2024

Study Registration Dates

First Submitted

March 10, 2023

First Submitted That Met QC Criteria

March 28, 2023

First Posted (Actual)

March 30, 2023

Study Record Updates

Last Update Posted (Actual)

February 5, 2024

Last Update Submitted That Met QC Criteria

February 2, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe